A failure-to-warn claim in product liability law holds a manufacturer or seller responsible when a product injures someone because it was sold without adequate warnings about a hidden danger. The product doesn’t need to be physically defective. If it reaches consumers without the safety information a reasonable manufacturer would have provided, the law can treat it as defective on that basis alone. Winning the claim requires showing the warning was missing or inadequate, the risk wasn’t one an ordinary user would spot, and the absence of the warning actually caused the harm.
When a Missing Warning Makes a Product Defective
Two legal standards drive most of these cases. The Restatement (Second) of Torts § 388 imposes liability on a supplier who knows a product is likely to be dangerous, has no reason to believe users will recognize the danger on their own, and fails to take reasonable steps to tell them. The U.S. Supreme Court has cited this standard in describing a manufacturer’s general duty of care, noting that the obligation to warn arises when a manufacturer “knows or has reason to know” its product is dangerous and “has no reason to believe” users will realize the hazard themselves.1The American Law Institute. U.S. Supreme Court Cites Torts 2d and Torts 3d
The Restatement (Third) of Torts: Products Liability § 2(c) frames the same idea differently. A product is defective when its foreseeable risks could have been reduced or avoided through reasonable instructions or warnings, and the absence of those warnings makes the product not reasonably safe.2Open Casebook. Restatement (3d.) (Products Liability) 2: Categories of Product Defect Which standard applies depends on the state, but the practical floor is the same: a manufacturer that knows about a risk and stays silent has sold a defective product, even if the product works exactly as designed.
What Makes a Warning Adequate
A generic “use with caution” sticker doesn’t satisfy the duty to warn. Courts weigh whether a warning would actually reach the user in time and communicate the real nature of the danger. That analysis breaks into placement, content, and format.
Placement matters because a warning buried on page 47 of a manual won’t protect a manufacturer if the hazard can cause immediate harm during first use. The warning needs to appear where the user will encounter it at the moment the risk is relevant, on the product itself when possible rather than inside the box. Courts routinely find warnings inadequate when they’re physically present but practically invisible.
Content has to describe the specific hazard, not just gesture at it. Calling a chemical “irritating” when prolonged exposure causes permanent respiratory damage misrepresents the severity of the risk. An adequate warning also tells the user how to avoid the danger. Labeling something flammable without instructing the user to keep it away from heat sources leaves the job half done.
Format is governed in much of the industry by the ANSI Z535.4 standard, which ties signal words to hazard severity. “Danger” (white text on red) indicates a situation that will result in death or serious injury if not avoided. “Warning” (black text with an orange alert symbol) signals a hazard that could result in death or serious injury. “Caution” (black on yellow) covers risks of minor or moderate injury.3ANSI. Product Safety Signs and Labeling: ANSI Z535.4-2023 Using “Caution” on a product that poses a lethal risk is the kind of mismatch that sinks a manufacturer in court. The standard also requires a message panel explaining the hazard, the likely consequence, and how to avoid it.
Hidden Risks Versus Obvious Dangers
The duty to warn applies to hazards that aren’t apparent to an ordinary consumer. A kitchen knife is obviously sharp. A manufacturer doesn’t need a label explaining that. But when a product creates risks a reasonable person wouldn’t anticipate through common sense or observation, the manufacturer has to disclose them.1The American Law Institute. U.S. Supreme Court Cites Torts 2d and Torts 3d
The clearest examples involve long-term or cumulative exposure. A cleaning product might work perfectly for years while gradually causing organ damage, the kind of danger no consumer would detect until too late. Internal mechanical failures fit here too: a bolt inside a pressure vessel that’s prone to fracturing under repeated use creates a hidden hazard even though the product looks and performs fine. Chemical sensitivities to ingredients that aren’t widely recognized as harmful also require disclosure. These latent risks are where failure-to-warn liability carries the most force, because the consumer had no realistic way to protect themselves without the information the manufacturer withheld.
Who Can Be Held Liable
Liability for missing warnings doesn’t stop with the company whose name is on the box. Every entity in the distribution chain can face exposure, from the original manufacturer to component suppliers, wholesalers, and retailers. The manufacturer usually carries the heaviest burden because it designed the product and is best positioned to identify and test for risks. A component supplier that provides an inherently dangerous part without flagging the hazard to the final assembler can share in that liability.
Retailers and wholesalers aren’t automatically off the hook. A seller who learns about a defect through customer complaints has an independent duty to notify future buyers. Any seller who removes or obscures warning labels on packaging takes on the liability the manufacturer tried to avoid by including those labels in the first place.
The Post-Sale Duty
The obligation can continue after the sale. Under the Restatement (Third) of Torts: Products Liability § 10, a manufacturer who discovers a previously unknown danger after selling a product may be required to warn buyers who already own it. This post-sale duty applies when the manufacturer learns the product poses a substantial risk, can identify and reach the affected users, and the severity justifies the effort of issuing a warning. This is the legal underpinning for product recall notices and post-sale safety bulletins. A manufacturer that discovers a serious risk and goes quiet faces far worse exposure than one that acts promptly.
Special Rules for Prescription Drugs and Medical Devices
Pharmaceutical manufacturers operate under the learned intermediary doctrine, which shifts the duty to warn from the patient to the prescribing physician. The reasoning is that a doctor is in the best position to evaluate the risks of a medication, weigh them against the benefits for a specific patient, and communicate what matters. So long as the drug manufacturer provides adequate warnings to physicians through package inserts, prescribing guides, and direct communications, it generally has no separate obligation to make sure those warnings reach patients directly.
The doctrine has limits. Direct-to-consumer drug advertising has prompted some courts to question whether the physician still functions as a true gatekeeper when a manufacturer markets aggressively to patients and encourages them to ask their doctor for a specific medication.
Medical devices sit in a different place because of federal preemption. The Supreme Court held in Riegel v. Medtronic that when the FDA has granted a medical device premarket approval, state failure-to-warn claims are preempted because they would impose requirements different from or additional to the federal ones. For prescription drugs, the Court reached the opposite result in Wyeth v. Levine, holding that FDA approval of a drug’s labeling does not automatically shield the manufacturer from state-law claims that the label was inadequate.4Cornell Law Institute. Wyeth v. Levine That split between drugs and devices can decide whether a claim survives at all.
Foreseeable Misuse Still Requires a Warning
Manufacturers can’t limit their warnings to a product’s intended purpose and stop there. If a predictable misuse creates a non-obvious risk, the manufacturer has to warn about it. The test is whether the misuse was reasonably foreseeable, not whether the manufacturer endorsed it. A consumer who uses a product in a way the manufacturer didn’t intend but easily could have predicted is still owed a warning about the risks of that use. Truly bizarre and unforeseeable misuse is a different story, and the manufacturer isn’t on the hook for failing to anticipate it.
Proving the Missing Warning Caused the Injury
Showing a warning was missing or inadequate is only half the case. The plaintiff also has to prove that the missing warning caused the injury, meaning the outcome would have been different if proper information had been provided.
The But-For Test
The core question is straightforward: but for the absence of the warning, would the injury have occurred?5Cornell Law Institute. But-for Test If a consumer would have been hurt regardless, because they never read labels at all or because no warning could have prevented the particular chain of events, then the missing warning wasn’t the cause of the harm, and the claim fails. Courts examine the plaintiff’s actual behavior. Did they read warnings on similar products? Did they have the ability to follow safety instructions? Would the specific warning have changed what they did?
The Heeding Presumption
Proving a hypothetical is hard. Roughly 20 states have adopted a heeding presumption to deal with that problem. Once a plaintiff shows an adequate warning was absent, courts presume the plaintiff would have read and followed one if it had existed. The burden then shifts to the manufacturer to rebut the presumption by showing the consumer would have ignored the warning anyway. States including Arizona, Kansas, Kentucky, New Jersey, and Texas have adopted versions of this presumption, though specifics vary and Texas limits it for prescription products. In states that don’t recognize it, plaintiffs carry the full burden of proving they would have changed their behavior.
Defenses Manufacturers Raise
Open and Obvious Danger
The most common defense is that the risk was obvious enough that no warning was needed. A manufacturer doesn’t have to tell consumers that fire is hot or that a saw blade can cut skin. The question is whether an ordinary person using common sense would recognize the danger. When courts accept this defense, they’re saying the product isn’t defective for lack of a warning because a reasonable consumer already understood the hazard.
Sophisticated User
When a product is sold to trained professionals rather than general consumers, manufacturers may argue those buyers already had the specialized knowledge a warning would have conveyed. This defense succeeds when the professional user knew, or should have known given their training and experience, the nature of the risk, its severity, and how to minimize it. The standard is measured by what the class of professional users generally knows, not what the individual plaintiff happened to know.
State of the Art
A manufacturer may argue that the risk was scientifically unknowable when the product was sold. If no available research, testing, or scientific knowledge would have revealed the hazard, the manufacturer can’t be faulted for failing to warn about something nobody in the industry could have identified. This defense matters most in cases involving long-latency injuries where medical or scientific understanding has advanced since the product left the factory.
Comparative Fault and Product Misuse
In states that apply comparative fault to product liability, a manufacturer can argue the plaintiff’s own behavior contributed to the injury. If the consumer ignored existing warnings, used the product in a completely unforeseeable way, or kept using it after discovering the danger, the damage award may be reduced in proportion. In a few states that still follow contributory negligence rules, the plaintiff’s own fault can bar recovery entirely.
Federal Preemption
When a product is subject to federal labeling requirements, manufacturers sometimes argue that compliance shields them from state failure-to-warn claims. The strength of this defense varies by product category. For FDA-approved medical devices that went through premarket approval, preemption is strong. For prescription drugs, the Supreme Court has held that FDA label approval alone does not preempt state claims, because manufacturers can strengthen their warnings under federal law without prior FDA approval.4Cornell Law Institute. Wyeth v. Levine For pesticides and other products regulated under separate federal statutes, preemption analysis turns on whether the state-law claim would require labeling different from what the federal scheme mandates.
Deadlines to File
Every state imposes a statute of limitations on product liability claims, and missing the deadline means losing the right to sue regardless of how strong the case is. The windows range from one year in a couple of states to six years in a handful of others, with two to three years being the most common. The clock usually starts when the injury occurs, but for latent injuries that don’t produce symptoms for years, many states apply a discovery rule that delays the start date until the plaintiff knew or reasonably should have known about the injury and its cause.
The discovery rule is especially important in failure-to-warn cases because the injuries often involve gradual harm from long-term exposure. A person who develops a chronic condition years after using a product may not connect the illness to the product until a diagnosis or emerging research points to the link. Some states also impose a separate statute of repose, which sets an absolute outer deadline measured from the date of sale or manufacture, cutting off claims even if the injury hasn’t yet been discovered. Checking your state’s specific deadlines early is one of the most important steps.
Damages You Can Recover
A successful failure-to-warn claim can produce two broad categories of compensation. Economic damages cover quantifiable financial losses: medical bills, rehabilitation costs, lost wages from time away from work, and property damage the defective product caused. Non-economic damages address the harder-to-measure harms like physical pain, emotional distress, diminished quality of life, and damage to close relationships.
In cases involving particularly egregious conduct, where a company knew about a serious risk and deliberately buried the information to protect sales, courts may award punitive damages on top of compensatory recovery. Punitive damages aren’t designed to compensate the plaintiff. They exist to punish the defendant and discourage similar behavior. Most states set a high bar, requiring proof of reckless disregard for consumer safety or intentional concealment, but when they apply, punitive awards can dwarf the compensatory side of the verdict.